Are low-priced drugs becoming an endangered species?

A new report by Canada's drug price regulator warns that new medicines are becoming increasingly expensive. Almost half of the new drugs coming on the market in 2016 and 2017 were "orphan" drugs aimed at treating rare diseases, with the average cost per patient approaching $1 million a year.

from CBC | Canada News https://ift.tt/2GLFPnu